Home Top Movers RedHill Biopharma Ltd. (RDHL) looks promising while other stocks are down

RedHill Biopharma Ltd. (RDHL) looks promising while other stocks are down

RedHill Biopharma Ltd. (RDHL) shares are trending up 5.86% to $8.85 in the pre-opening hours. Considering the past, we will study various developments that may have caused RDHL to move forward or backward. Within the past five business days, shares rose 7.32% percent and declined -14.95 percent. Somewhere during the previous quarter, the stock dropped -13.64 percent. In the six months ending July 31, 2007, the stock’s output increased 21.16%, while annual general production increased 42.18 percent. At the end of the calendar year, the Company is performing better than the beginning.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

Company Info

RedHill Biopharma Ltd., through its subsidiary RedHill Biopharma Israel Ltd., commercializes and develops pharmaceutical products.

Read More

What’s the latest…

The Company announced on January 14, 2021, that it had closed its previously announced underwritten offering of 3,188,776 American Depositary Shares (ADSs) of the Company for $7.84 per ADS. An ADS represents ten ordinary shares of the Company, each valued at NIS 0.01 per share.

RedHill Biopharma Ltd. (RDHL) revealed on January 12, 2021, that the underwriter has increased the size of the previously announced offer and agreed to buy 3,188,776 American Depositary Shares of the Company for $7.84 per ADS, less underwriting discounts and commissions. The closing of this offering is expected to occur on or about January 14, 2021, subject to satisfying the customary closing conditions. Each ADS represents ten ordinary shares of the Company, each worth NIS 0.01 per share.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

Analysts Eye

Based on BTIG Research’s research note dated September 11, 2020, the stock was rated a Buy. The stock was rated a Strong Buy by WBB Securities in a research note published on July 12, 2019.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Prompted INVO Biosciences’ After-Hours Rally?

A spike in INVO Bioscience, Inc's (NASDAQ: INVO) stock price after-hours drove its price up 83.28% on Monday. In regular sessions, through the end...

The Opgen (OPGN) Stock Is High Today, Reason?

OpGen, Inc. (Nasdaq: OPGN), a company that makes use of the power of molecular diagnostics and bioinformatics to treat infectious diseases, is showing strength...

Why Nano Dimension (NNDM) Leapt 7% In Aftermarket Trading On Friday?

After-hours trading on Friday saw Nano Dimension Corp (Nasdaq: NNDM) hit $7.97 a share rising 4.73%. The stock saw a decline of -2.31% to...

What Caused The Anchiano Therapeutics (ANCN) To Continue Rally After-Hours?

The clinical-stage biotech company Anchiano Therapeutics Ltd. (Nasdaq: ANCN) saw its stock rising 40.12% in after-hours trades on Friday. The price of the company’s...

Are The Financial Results Weighing On Senseonics (SENS) Stock In Premarket Today?

Shares of medical technology Senseonics Holdings, Inc. (NYSE American: SENS) has been declining -9.67% in pre-market session today falling to a price level of...

Tron (TRX) Working Hard on DeFi Development; Where is TRX Heading?

Tron 2021 Global DeFi Hackathon developer contest is one of its $120 million TRON DeFi Entrepreneurial Alliance Support Program.  TRON (TRX) is making sure that it...

Mark Cuban backs Dogecoin (DOGE) and says Dallas Mavericks are the largest merchant of Meme Coin worldwide

After Elon Musk, Cuban comes out in favor of the meme coin. Dogecoin (DOGE) is one of the most anticipated cryptocurrencies of the future. Back...

The Opgen (OPGN) Stock Is High Today, Reason?

OpGen, Inc. (Nasdaq: OPGN), a company that makes use of the power of molecular diagnostics and bioinformatics to treat infectious diseases, is showing strength...

Related News

The Opgen (OPGN) Stock Is High Today, Reason?

OpGen, Inc. (Nasdaq: OPGN), a company that makes use of the power of molecular diagnostics and bioinformatics to treat infectious diseases, is showing strength...

Why Is Xpresspa (XSPA) Rocketing 16% Before Market Open Today?

The global health and wellness company XpresSpa Group, Inc. (Nasdaq: XSPA) has been seeing stock rising 16.05% (as of 08:10 a.m. EST) in pre-market...

What Gave GEVO Stock A 9% Boost In Aftermarket Trading On Friday?

Gevo, Inc. (NASDAQ: GEVO) shares risen by 9.46% on Friday in after-hours trading, rising the stock price to $7.64. The company saw its stock...

Adaptive Biotechnologies Corporation (ADPT) Leapt 18% In Extended Trading. Here’s Why?

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, has seen its share price surging 18.16% in extended trading to $49.90.

Evofem Biosciences (EVFM) – Stock Fell In Early Trades Today: Why?

Shares of the biopharmaceutical company Evofem Biosciences, Inc., (NASDAQ: EVFM) have been sinking in the early trades today. The stock was buoying at $2.205...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.